Colorectal cancer (CRC) comprises approximately 10% of all cancers and is a major cause of cancer-related morbidity and mortality despite current diagnostic and treatment improvements. DNA damage and altered DNA replication through the deregulation of related genes cause genomic instability in sporadic CRC. DNA repair is very complex; many factors play a role to ensure that the restoration of errors occurs during the transfer of genetic material. MutL homolog 1 (MLH1) is one of the vital DNA repair genes responsible for genomic stability. Together with environmental factors, the genetic background may be associated with CRC development; thus, genetic polymorphisms are considered as risk factors. The present prospective casecontrol study aimed to determine the association between 93G>A and I219V polymorphisms of MLH1 and CRC susceptibility in a Turkish population. The genotyping of 158 patients and 164 age-and sex-matched controls was performed by polymerase chain reaction-restriction fragment length polymorphism. Two variants, 93G>A and I219V, were associated with an increased risk of CRC. Individuals with A allele of 93G>A had an approximately 2-fold risk (OR: 1.92, 95% CI: 1.22-3.04; p<0.01) and those with G allele of I219V had an approximately 3-fold risk (OR: 2.82, 95% CI: 1.76-4.52; p<0.01) of developing CRC. Our results provide novel information for understanding the influence of MLH1 on CRC risk in the Turkish population; however, further studies with a larger number of participants are required.
INTRODUCTION
Colorectal cancer (CRC), for many years, is in the third place of all cancers both in men and women, and is a major cause of cancer-related morbidity and mortality (Berndt et al. 2007 , Siegel et al. 2015 . Genetic background covers a great position in the complexity of the CRC aetiology; and together with environmental factors, CRC incidence is varied among different populations (Aykan 2000, Haggar and Boushey 2009; Huxley et al. 2009 ). Recently, several pathways contributed to cancer development have been identified. It is well known that genomic instability is the origin triggers as well as other cancer-related mechanisms in hereditary cancers. However, in sporadic cancers, genomic instability is a consequence of DNA damage and alteration in DNA replication due to deregulation of the related genes in addition with impaired DNA repair (Anderson 2001 , Negrini et al. 2010 . Therefore, DNA repair mechanisms play crucial role in cancer prevention through maintaining genomic stability and DNA integrity (Abbas et al. 2013 ).
DNA repair is a very complex process in which many factors play a role together starting from the identification of the damaged region to post-replication. Mismatch repair (MMR) is one of the major mechanisms in DNA repair and MMR genes play MLH1 -93G>A and I219V polymorphisms are susceptible to increased risk of sporadic colorectal cancer in a Turkish population Ezgi Öztaş 1, *, Umay Çilingir 1 a key role in fixing several errors such as insertions and deletions that occurred during the replication (Milanowska et al. 2010) . MutL Homolog 1 (MLH1), a member of MMR genes, has been suggested to be associated with both hereditary and sporadic CRCs through either genetic polymorphisms or epigenetic regulations (Richter et al. 2014 , Zhang et al. 2016 , Savio et al. 2017 ). For over a decade, the association between MLH1 polymorphisms and CRC has been investigated; however, a definite conclusion has not been agreed (Burmester et al. 2004 , Yu et al. 2006 , Rajender et al. 2010 , Valentin et al. 2012 . It should be considered that conflicted results may be due to diversities between populations as well as numbers of the participants; therefore, further studies conducted with different populations were needed. In this present study, effects of MLH1 polymorphisms on sporadic CRC susceptibility were evaluated in a Turkish population for the first time.
MATERIALS AND METHODS
A prospective case-control study was conducted with Turkish participants from Hospital of İstanbul University between 2011 and 2016. Adenocarcinoma of the colon or rectum was confirmed by routine laboratory and histological evaluations in 158 participants. Ethnic-age-sex-matched controls who had no history of any type of cancer were selected randomly from various divisions of the hospital and 164 participants were evaluated. All participants were provided informed consent. Study was conducted in accordance with the Helsinki Declaration and was approved by the ethics committee of İstanbul University (2016/1238).
Venous blood was collected into vacutainer EDTA tubes and within the same day genomic DNA was extracted by standard phenol-chloroform extraction protocol. DNA concentrations were measured by Take3 Plate on Epoch microplate spectrophotometer (BioTek, Winooski, USA) and diluted as appropriate. Genotyping of -93G>A and I219V was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Primers were synthesized by Sentromer DNA Technologies Laboratory (İstanbul, Turkey) and restriction enzymes were purchased by New England Biolabs (Hitchin, England). All other chemicals and plastic-ware were obtained from Sigma-Aldrich (St. Louis, Missouri, USA), Merck (Darmstadt, Germany) and Isolab GmbH (İstanbul, Turkey) as suitable grade for molecular research. Amplification and restriction conditions were shown in Table 1 . Restriction products were identified on 2% agarose gels stained with ethidium bromide by a UV transilluminator. In each run, controls of known wild-type, heterozygous, and mutant genotype were included to check the accuracy that yielded 100% concordance.
All statistical analyses were carried out by using Statistical Package for Social Sciences (SPSS, version 21.0) and GraphPad Prism (version 5.0a) programs. Hardy-Weinberg equilibrium was tested by using chi-square (χ 2 ). The dominant model
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Istanbul J Pharm 47 (2): 63-67 which is the wild type was chosen as reference group was used in genotyping analysis. Data comparisons were done by using Fisher's exact test; and, the odds ratios (ORs) and 95% confidence intervals (CIs) were estimated to evaluate the association between cases and controls. A two-tailed p<0.05 was considered to indicate a statistically significant difference.
RESULTS
MLH1 -93G>A and I219V polymorphisms were evaluated for the sporadic CRC susceptibility with the Turkish participants. All samples were genotyped with at least 93.1% successful rate and 100% concordance. There were no significant differences between cases and controls for age and sex, and genotype distribution was found to be consistent with the Hardy-Weinberg equilibrium (p>0.05) suggesting that the studied population was unbiased.
Genotype distributions of studied SNPs were summarized in 
DISCUSSION
MMR system is responsible for impeccable DNA replication. As a result of inability to correct the errors during DNA replication, the length of microsatellite alleles changes due to the insertion and deletion of repetitive units in DNA. MLH1, a member of MMR genes, is one of the most studied genes due to its crucial role in maintaining the genomic stability through DNA repair. Genetic polymorphisms alone or together with epigenetic regulations in MLH1 may cause microsatellite instability (MSI); thus may alter the cancer susceptibility (Berndt et al. 2007 , Curtin 2012 .
Because of the genomic instability is the initial factor in hereditary cancers, many researchers focused on the role of MLH1 polymorphisms in Lynch Syndrome (LS) and/or Hereditary Nonpolyposis Colorectal Cancer (HNPCC) susceptibility. Rajender et al. (2010) reported that MLH1 R659X (1975C>T) mutation is associated with HNPCC and 655A>G locus is highly polymorphic whereas I219V has no influence in Indian population. Valentin et al. (2012) reported that MLH1 V384D (T>A) and Q701K (C>A) polymorphisms might increase the risk. Also, Ohsawa et al. (2009) and Peng et al. (2015) reported that MLH1 V384D polymorphism might be associated with sporadic CRC in Japanese and Chinese populations, respectively.
It is well known that, MSI is occurred in the half of the LS patients (Tantoğlu 2012) . Campbell et al. (2009) suggested MSI-positive patients carrying -93A allele has 2-fold increased risk of colon cancer while there is no association between MSI-negative patients. However, in the same study, it was found that -93A allele is associated with smoking in MSInegative patients. Additionally, Whiffin et al. (2011) reported that -93G>A polymorphism is associated with increased risk of both MSI-positive CRC and overall CRC.
Besides polymorphic changes, epigenetic regulations in MLH1 may alter the risk of CRC. Mrkonjic et al. (2010) suggested that -93G>A polymorphism is associated with CRC in MSI-positive patients due to protein loss through methylation in the MLH1 promotor region. Similarly, Kim et al. (2004) reported that I219V polymorphism and MLH1 protein expression is correlated; however, Santibanez Koref et al. (2010) did not found any association between I219V polymorphism and MLH1 methylation in CRC patients.
Our results suggested that both -93G>A and I219V variants are associated with 2-fold and 3-fold increased risk of sporadic CRC in Turkish population, respectively. Similarly, Allan et al. (2008) reported that -93A variant is increased the risk of CRC approximately 3-fold; and suggested that -93G>A polymorphisms increased the risk of MSI-positive CRC. In addition, Milanizadeh et al. (2013) suggested that MLH1 I219V polymorphism is associated with sporadic CRC in East Asia.
On the other hand, Yu et al. (2006) reported that MLH1 -93G>A polymorphism is not associated with colorectal adenoma and/or hyperplastic polyposis; however, -93A variant increased the 2-fold in the risk of adenoma and 10-fold in the risk of hyperplastic polyposis 10-fold among smokers. Similarly, Liu et al. (1995) and Peng et al. (2015) suggested that MLH1 -93G> A, I219V and G39E polymorphisms were not associated with neither adenomatous polyps nor colorectal polyps. Also, Picelli et al. (2010) found that MLH1 I219V polymorphism increased the risk of CRC risk; however, the association did not reach statistical significance.
CONCLUSION
The data is the first in understanding the influence of MLH1 on CRC risk in Turkish population, and suggested that -93G>A and I219V polymorphisms might be associated with sporadic CRC susceptibility. However, it should be considered that conflicted results may be due to diversities between populations as well as numbers of the participants; therefore, further studies conducted with different populations are needed.
